Skip to content

Ionis Pharmaceuticals IONS Inventory Currentand Noncurrent

Inventory Currentand Noncurrent at other companies

Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$30.83M+49.6%
Imperial Oil logo
Imperial OilIMO
$64M+12.3%
Tenet Healthcare logo
Tenet HealthcareTHC
-$407M-477%
IonQ logo
IonQIONQ
$124.57M+136%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$1.76M+84.5%
Biogen logo
BiogenBIIB
$223M

Other financials

Income statement

See full
Revenue$246.1M+87.0%
Gross profit$243.1M+86.8%
Operating income-$117.4M+20.0%
Net income-$92.5M+37.0%
EPS (diluted)-$0.56+39.8%

Balance sheet

See full
Cash & equivalents$173.4M-34.4%
Total debt$691.7M+334%
Total equity$491.4M+3.3%
Total assets$3.4B+22.6%

Cash flow

See full
Operating cash flow-$792.8M-426%
CapEx$21.8M+73.0%
Free cash flow-$814.6M-399%

Valuation

See full
Market cap$12.25B+159%
Enterprise value$12.77B+175%
P/S11.6×+5.0×

Profitability

See full
Gross margin98.4%-0.2pp
Operating margin-33.3%-11.0pp
Net margin-30.9%-10.5pp
FCF margin-77.4%+35.3pp

Returns & leverage

See full
Return on equity-67.6%-20.3pp
Debt / equity1.4×+1.1×
Current ratio4.1×-5.6×

Where this comes from

Reported directly by Ionis Pharmaceuticals in its filing.

Tagged under the XBRL concept ions:InventoryCurrentandNoncurrent.

The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ionis Pharmaceuticals's inventory currentand noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ionis Pharmaceuticals's inventory currentand noncurrent?
Ionis Pharmaceuticals (IONS) reported inventory currentand noncurrent of $26.19M in Q4 2025.
What does inventory currentand noncurrent mean?
The total value of all inventory held by the company.
How do you interpret inventory currentand noncurrent?
Rising total inventory relative to revenue may indicate slowing sales or supply chain inefficiencies, whereas stable levels suggest balanced production and demand.
How does inventory currentand noncurrent compare across companies?
Standard across the pharmaceutical industry to track total inventory investment relative to commercial revenue growth.